LYKALABSNSELyka Labs Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 8 Aug, 2025 · 17:40 IST

Lyka Labs Limited has informed the Exchange about General Updates

Nclt Scheme FiledStrategic Transactions View source PDFExplain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.6%Reaction day
₹104.88
prior close
₹104.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.8% vs market
Pharmaceuticals peers, median of 148sector+0.3%-0.9% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.7
10m
+1.1
15m
+1.6
30m
+1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.6+0.2-0.8+0.3-0.9
Next day
-2.3+0.2-2.5+0.3-2.6
2d
-3.7+0.9-4.6+0.6-4.3
3d
-4.8+0.1-4.8-0.3-4.4
4d
-4.6+1.6-6.2+0.5-5.2
5d
-4.7+2.8-7.6+0.6-5.3
1w
-5.0+3.0-8.1+0.8-5.8
15d
-3.7+2.8-6.5+0.1-3.8
1m
-4.7+3.1-7.7+1.5-6.1
2m
-5.8+1.4-7.2-1.5-4.3
3m
-11.3+1.4-12.7-4.2-7.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lyka Labs Limited informed the exchanges that the NCLT Ahmedabad Bench heard the Scheme of Amalgamation between Lyka Exports Limited (Transferor) and Lyka Labs Limited (Transferee) on 7th August 2025. The Regional Director and Income Tax Department submitted their replies with no objection to the scheme. The NCLT has reserved its order for formal pronouncement. This follows an earlier rejection of a prior petition, with the company now having refiled and completed all compliances. A formal disclosure will follow once the NCLT order is officially pronounced.

Likely market impact

The scheme is one step closer to approval, with no objections from regulatory bodies. If approved, Lyka Exports Limited will merge into Lyka Labs, which could simplify the group's structure. Shareholders should watch for the formal NCLT order and any subsequent share-swap ratio announcement.